Skip to main navigation Skip to search Skip to main content

A phylogenetics and variant calling pipeline to support SARS-CoV-2 genomic epidemiology in the UK

  • Rachel Colquhoun*
  • , Áine O’Toole
  • , Verity Hill
  • , J. T. McCrone
  • , Xiaoyu Yu
  • , Samuel M. Nicholls
  • , Radoslaw Poplawski
  • , Thomas Whalley
  • , Natalie Groves
  • , Nicholas Ellaby
  • , Nick Loman
  • , Tom Connor
  • , Andrew Rambaut
  • *Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

1 Citation (Scopus)

Abstract

In response to the escalating SARS-CoV-2 pandemic, in March 2020 the COVID-19 Genomics UK (COG-UK) consortium was established to enable national-scale genomic surveillance in the UK. By the end of 2020, 49% of all SARS-CoV-2 genome sequences globally had been generated as part of the COG-UK programme, and to date, this system has generated >3 million SARS-CoV-2 genomes. Rapidly and reliably analysing this unprecedented number of genomes was an enormous challenge. To fulfil this need and to inform public health decision-making, we developed a centralized pipeline that performs quality control, alignment, and variant calling and provides the global phylogenetic context of sequences. We present this pipeline and describe how we tailored it as the pandemic progressed to scale with the increasing amounts of data and to provide the most relevant analyses on a daily basis.

Original languageEnglish
Article numberveae083
JournalVirus Evolution
Volume10
Issue number1
DOIs
Publication statusPublished - 2024

Bibliographical note

Publisher Copyright:
© The Author(s) 2024. Published by Oxford University Press.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • SARS-CoV-2
  • genomic epidemiology
  • genomic surveillance
  • phylogenetics
  • software

Fingerprint

Dive into the research topics of 'A phylogenetics and variant calling pipeline to support SARS-CoV-2 genomic epidemiology in the UK'. Together they form a unique fingerprint.

Cite this